Genetically modified cold virus a ‘promising’ new TB vaccine

Researchers at McMaster University are heralding the success of early trials of a “booster” vaccine that could serve as a potent tool in global fight against tuberculosis.

In a report published on Wednesday in the journal Science Translational Medicine, researchers with the university’s Michael G. DeGroote School of Medicine detail a study they conducted with 24 human volunteers to test the safety of the vaccine.

Zhou Xing, a professor of pathology and molecular medicine at the McMaster Immunology Research Centre, said the test subjects developed no major side effects. Generally, their immune systems responded well to the vaccine.

“We are excited,” Xing said. “We are encouraged by these promising results.”

Read the full, original story here: “Genetically modified cold virus a ‘promising’ new TB vaccine”

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend